85 related articles for article (PubMed ID: 2441410)
1. Release of myocardial depressant factor (MDF) during cardiopulmonary bypass (CPB): influence of corticosteroids (methylprednisolone) and protease inhibitor (aprotinin).
Coraim FI; Laufer G; Ilias W; Wollenek G; Wolner E
Prog Clin Biol Res; 1987; 236A():611-20. PubMed ID: 2441410
[No Abstract] [Full Text] [Related]
2. Effects of methylprednisolone and aprotinin on phospholipase D activity of leukocytes in systemic inflammatory response induced by cardiopulmonary bypass.
Wu M; Lu YB; Jiang B; Xu SW; Chen RK; Zhou HL
Acta Pharmacol Sin; 2001 Oct; 22(10):913-7. PubMed ID: 11749774
[TBL] [Abstract][Full Text] [Related]
3. The effects of aprotinin and steroids on generation of cytokines during coronary artery surgery.
Türköz A; Ciğli A; But K; Sezgin N; Türköz R; Gülcan O; Ersoy MO
J Cardiothorac Vasc Anesth; 2001 Oct; 15(5):603-10. PubMed ID: 11688002
[TBL] [Abstract][Full Text] [Related]
4. [Current status of the myocardial depressant factor (MDF) and shock].
Favaro R; Pelaia P
Minerva Anestesiol; 1979; 45(7-8):594-600. PubMed ID: 548819
[No Abstract] [Full Text] [Related]
5. A study of the myocardial depressant factor and its relative influence in drug/alcohol mortality.
Manning TJ; Williams LE; Lynch VD; Bidanset JH; Drake W; Lukash L
J Forensic Sci; 1980 Jul; 25(3):550-63. PubMed ID: 7400768
[TBL] [Abstract][Full Text] [Related]
6. Factor V Leiden does not affect bleeding in aprotinin recipients after cardiopulmonary bypass.
Boehm J; Grammer JB; Lehnert F; Dietrich W; Wagenpfeil S; Wildhirt SM; Wottke M; Braun S; Lange R; Bauernschmitt R
Anesthesiology; 2007 Apr; 106(4):681-6. PubMed ID: 17413905
[TBL] [Abstract][Full Text] [Related]
7. [Positive modification of hemodynamics in post cardiac surgery patients by hemofiltration. Improved method for the demonstration of myocardial depressant factor (MDF) in hemofiltrate].
Coraim F; Pauser G; Stellwag F; Werner T; Ziegler W
Anaesthesist; 1985 May; 34(5):236-40. PubMed ID: 4025793
[TBL] [Abstract][Full Text] [Related]
8. Effects of corticosteroids on inflammatory response following cardiopulmonary bypass.
Anić D; Gasparović H; Ivancan V; Batinić D
Croat Med J; 2004 Apr; 45(2):158-61. PubMed ID: 15103751
[TBL] [Abstract][Full Text] [Related]
9. Modified paper chromatographic method for assay of myocardial depressant factor.
Yamada T; Pettit GW
Circ Shock; 1977; 4(4):379-86. PubMed ID: 598007
[TBL] [Abstract][Full Text] [Related]
10. The effect of methylprednisolone treatment on the cardiopulmonary bypass-induced systemic inflammatory response.
Bourbon A; Vionnet M; Leprince P; Vaissier E; Copeland J; McDonagh P; Debré P; Gandjbakhch I
Eur J Cardiothorac Surg; 2004 Nov; 26(5):932-8. PubMed ID: 15519185
[TBL] [Abstract][Full Text] [Related]
11. Cardiopulmonary and systemic effects of methylprednisolone in patients undergoing cardiac surgery.
Liakopoulos OJ; Schmitto JD; Kazmaier S; Bräuer A; Quintel M; Schoendube FA; Dörge H
Ann Thorac Surg; 2007 Jul; 84(1):110-8; discussion 118-9. PubMed ID: 17588396
[TBL] [Abstract][Full Text] [Related]
12. Effects of nafamostat mesilate and minimal-dose aprotinin on blood-foreign surface interactions in cardiopulmonary bypass.
Kaminishi Y; Hiramatsu Y; Watanabe Y; Yoshimura Y; Sakakibara Y
Ann Thorac Surg; 2004 Feb; 77(2):644-50. PubMed ID: 14759453
[TBL] [Abstract][Full Text] [Related]
13. Cardiopulmonary bypass-induced inflammation: is it important?
Hill GE
J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):21-5. PubMed ID: 9583572
[TBL] [Abstract][Full Text] [Related]
14. [Myocardial depressant factor in patients with low output syndrome].
Senoo Y; Mondori E; Nawa S; Kawakami S; Teramoto S
Kyobu Geka; 1977 Apr; 30(4):313-7. PubMed ID: 559194
[No Abstract] [Full Text] [Related]
15. Methylprednisolone does not benefit patients undergoing coronary artery bypass grafting and early tracheal extubation.
Chaney MA; Durazo-Arvizu RA; Nikolov MP; Blakeman BP; Bakhos M
J Thorac Cardiovasc Surg; 2001 Mar; 121(3):561-9. PubMed ID: 11241092
[TBL] [Abstract][Full Text] [Related]
16. [Effects of adrenal cortex hormone in endotoxic shock, with special reference to its effect on cardiac function and myocardial depressant factor].
Kosugi I; Yamaguchi Y; Kawaguchi T; Kawashima Y; Okada K
Masui; 1976 Feb; 25(2):171-8. PubMed ID: 943602
[No Abstract] [Full Text] [Related]
17. Delayed appearance of a circulating myocardial depressant factor in burn patients.
De Santis D; Phillips P; Spath MA; Lefer AM
Ann Emerg Med; 1981 Jan; 10(1):22-4. PubMed ID: 7458026
[TBL] [Abstract][Full Text] [Related]
18. Prevention of TNFalpha-associated myocardial dysfunction resulting from cardiopulmonary bypass and cardioplegic arrest by glucocorticoid treatment.
Liakopoulos OJ; Teucher N; Mühlfeld C; Middel P; Heusch G; Schoendube FA; Dörge H
Eur J Cardiothorac Surg; 2006 Aug; 30(2):263-70. PubMed ID: 16829094
[TBL] [Abstract][Full Text] [Related]
19. The myocardial depressant factor (MDF) in acute hemorrhagic pancreatitis.
Ito K; Ramirez-Schon G; Shah PM; DelGuercio LR; Reynolds BM
Trans Am Soc Artif Intern Organs; 1980; 26():149-52. PubMed ID: 7245473
[TBL] [Abstract][Full Text] [Related]
20. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
